Correlation Between Inhibrx and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Travere Therapeutics, you can compare the effects of market volatilities on Inhibrx and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Travere Therapeutics.
Diversification Opportunities for Inhibrx and Travere Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Travere is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Travere Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Travere Therapeutics. In addition to that, Inhibrx is 1.43 times more volatile than Travere Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.17 per unit of volatility. If you would invest 696.00 in Travere Therapeutics on September 3, 2024 and sell it today you would earn a total of 1,185 from holding Travere Therapeutics or generate 170.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Travere Therapeutics
Performance |
| Timeline |
| Inhibrx |
| Travere Therapeutics |
Inhibrx and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Travere Therapeutics
The main advantage of trading using opposite Inhibrx and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |